Insider Selling: Arch Capital Group (NASDAQ:ACGL) Director Sells 3,000 Shares of Stock

Key Points

  • Arch Capital CEO Nicolas Papadopoulo sold 21,930 shares on March 10 for a total of $2,112,078.30, trimming his stake by 2.45% to 871,594 shares valued at about $83.94M.
  • Arch beat expectations for the quarter with $2.98 EPS vs $2.34 expected and $4.93B revenue, while institutional ownership is high at 89.07% and analysts hold a consensus "Hold" rating with a $109.20 target.

Arch Capital Group Ltd. (NASDAQ:ACGL - Get Free Report) Director Brian Posner sold 3,000 shares of the business's stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $17.11, for a total transaction of $51,330.00. Following the completion of the sale, the director directly owned 2,000 shares of the company's stock, valued at approximately $34,220. The trade was a 60.00% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Arch Capital Group Price Performance

ACGL traded up $0.17 during midday trading on Friday, hitting $94.39. 543,858 shares of the company traded hands, compared to its average volume of 2,015,713. The business has a 50 day simple moving average of $96.21 and a two-hundred day simple moving average of $93.00. Arch Capital Group Ltd. has a 52-week low of $82.44 and a 52-week high of $103.39. The company has a market capitalization of $33.58 billion, a price-to-earnings ratio of 8.12, a PEG ratio of 3.86 and a beta of 0.40. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.13.




Arch Capital Group (NASDAQ:ACGL - Get Free Report) last released its earnings results on Monday, February 9th. The insurance provider reported $2.98 EPS for the quarter, topping analysts' consensus estimates of $2.34 by $0.64. Arch Capital Group had a net margin of 22.07% and a return on equity of 16.73%. The business had revenue of $4.93 billion during the quarter, compared to analysts' expectations of $3.94 billion. During the same quarter in the previous year, the company earned $2.26 earnings per share. On average, equities analysts forecast that Arch Capital Group Ltd. will post 8.42 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Arch Capital Group

A number of institutional investors have recently added to or reduced their stakes in ACGL. World Investment Advisors grew its holdings in Arch Capital Group by 19.8% in the 4th quarter. World Investment Advisors now owns 6,930 shares of the insurance provider's stock valued at $665,000 after buying an additional 1,145 shares in the last quarter. Meadowbrook Advisors Group LLC purchased a new position in shares of Arch Capital Group during the 4th quarter worth $1,319,000. Hsbc Holdings PLC boosted its position in shares of Arch Capital Group by 4.8% during the 4th quarter. Hsbc Holdings PLC now owns 389,698 shares of the insurance provider's stock valued at $37,551,000 after acquiring an additional 17,832 shares during the last quarter. Pure Financial Advisors LLC acquired a new position in shares of Arch Capital Group during the 4th quarter valued at about $207,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in shares of Arch Capital Group by 95.3% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,701 shares of the insurance provider's stock valued at $163,000 after purchasing an additional 830 shares during the period. Hedge funds and other institutional investors own 89.07% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Mizuho increased their target price on Arch Capital Group from $95.00 to $102.00 and gave the company a "neutral" rating in a report on Thursday, February 12th. Barclays set a $104.00 price target on Arch Capital Group and gave the stock an "equal weight" rating in a research note on Thursday, January 8th. The Goldman Sachs Group reiterated a "sell" rating and set a $93.00 price target (up from $84.00) on shares of Arch Capital Group in a research report on Wednesday, January 7th. Weiss Ratings upgraded Arch Capital Group from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, February 4th. Finally, Roth Mkm set a $110.00 target price on shares of Arch Capital Group and gave the stock a "buy" rating in a research note on Tuesday, December 2nd. Nine investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $109.20.

View Our Latest Research Report on ACGL

Arch Capital Group Company Profile

(Get Free Report)

Arch Capital Group Ltd. (NASDAQ: ACGL) is a Bermuda-based insurance and reinsurance holding company that underwrites a broad range of property and casualty, mortgage, and specialty risk products. The company operates through a group of underwriting subsidiaries and platforms to provide insurance, reinsurance and related risk solutions tailored to commercial, institutional and individual clients.

Arch's product mix includes treaty and facultative reinsurance, primary casualty and property insurance, mortgage insurance and other specialty lines.

Further Reading

Insider Buying and Selling by Quarter for Arch Capital Group (NASDAQ:ACGL)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Arch Capital Group?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Arch Capital Group and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles